| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $358K | +164.0% |
| Cost of Revenue | $196K | +221.1% |
| Gross Profit | $162K | +117.4% |
| R&D Expense | $6.4M | +41.3% |
| SG&A Expense | $7.3M | -16.0% |
| Operating Income | -$27.2M | +25.6% |
| Interest Expense | $602K | -22.0% |
| Net Income | -$29.7M | +23.0% |
| EPS (Basic) | -$0.38 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | -61.2% |
| Accounts Receivable | $65K | +408.8% |
| Inventory | $73K | — |
| Current Assets | $3.2M | -43.1% |
| Total Assets | $78.7M | -11.8% |
| Current Liabilities | $4.6M | -29.4% |
| Long-term Debt | $7.9M | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.9M | -13.6% |
| Capital Expenditures | $2.1M | +143.5% |
| Investing Cash Flow | -$2.6M | -17.5% |
| Financing Cash Flow | $19.3M | +131.1% |
| Free Cash Flow | -$22.1M | -19.7% |
| +44.9% |
| EPS (Diluted) | -$0.31 | +55.1% |
| Total Liabilities |
| $5.5M |
| -62.1% |
| Stockholders' Equity | $73.3M | -2.2% |